Evogene (EVGN) Short Interest Ratio & Short Volume → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free EVGN Stock Alerts $0.77 -0.05 (-5.96%) (As of 03:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Evogene Short Interest DataCurrent Short Interest62,400 sharesPrevious Short Interest97,800 sharesChange Vs. Previous Month-36.20%Dollar Volume Sold Short$42,719.04Short Interest Ratio0.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares41,220,000 sharesPercentage of Shares Shorted0.15%Today's Trading Volume103,991 sharesAverage Trading Volume150,172 sharesToday's Volume Vs. Average69% Short Selling Evogene ? Sign up to receive the latest short interest report for Evogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVGN Short Interest Over TimeEVGN Days to Cover Over TimeEVGN Percentage of Float Shorted Over Time Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Evogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202462,400 shares $42,719.04 -36.2%N/A0.6 $0.68 4/30/202497,800 shares $67,755.84 +40.3%N/A0.6 $0.69 4/15/202469,700 shares $47,835.11 -19.4%N/A0.4 $0.69 3/31/202486,500 shares $64,875.00 +20.8%N/A0.5 $0.75 3/15/202471,600 shares $58,712.00 -47.5%N/A0.4 $0.82 2/29/2024136,300 shares $124,196.56 +25.7%N/A0.6 $0.91 Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024108,400 shares $81,137.40 -11.0%N/A0.5 $0.75 1/31/2024121,800 shares $93,177.00 -3.0%N/A0.8 $0.77 1/15/2024125,500 shares $117,719.00 -18.4%N/A0.8 $0.94 12/31/2023153,700 shares $129,108.00 -17.9%N/A1 $0.84 12/15/2023187,200 shares $131,189.76 -35.0%N/A1.3 $0.70 11/30/2023287,800 shares $187,127.56 +32.3%N/A2.3 $0.65 11/15/2023217,500 shares $143,898.00 +20.6%N/A2 $0.66 10/31/2023180,400 shares $86,429.64 -28.8%N/A1.3 $0.48 10/15/2023253,400 shares $118,616.54 -11.3%N/A1.6 $0.47 9/30/2023285,600 shares $167,504.40 +20.0%N/A1 $0.59 9/15/2023238,000 shares $159,698.00 -8.9%N/A0.7 $0.67 8/31/2023261,100 shares $194,075.63 -12.7%N/A0.7 $0.74 8/15/2023299,200 shares $238,163.20 -10.7%N/A0.8 $0.80 7/31/2023334,900 shares $354,994.00 -33.8%N/A1 $1.06 7/15/2023505,800 shares $708,120.00 -8.5%N/A1.7 $1.40 6/30/2023552,800 shares $591,496.00 +118.7%1.4%3.5 $1.07 6/15/2023252,800 shares $195,161.60 +13.0%0.6%2 $0.77 5/31/2023223,800 shares $134,324.76 -22.5%0.6%3.1 $0.60 5/15/2023288,700 shares $193,313.52 +13.4%0.7%3.9 $0.67 4/30/2023254,500 shares $149,111.55 -1.3%0.6%3.1 $0.59 4/15/2023257,900 shares $149,917.27 +2.6%0.7%2.8 $0.58 3/31/2023251,300 shares $158,319.00 +42.9%0.6%2.6 $0.63 3/15/2023175,900 shares $115,918.10 +11.2%0.4%1.6 $0.66 2/28/2023158,200 shares $120,232.00 -31.2%0.4%1.5 $0.76 2/15/2023230,000 shares $195,500.00 -7.9%0.6%2.1 $0.85 1/31/2023249,600 shares $199,655.04 +45.0%0.6%2.4 $0.80 1/15/2023172,200 shares $129,150.00 -0.9%0.4%1.9 $0.75 12/30/2022173,800 shares $121,660.00 -35.2%0.4%2 $0.70 12/15/2022268,100 shares $189,653.94 +42.6%0.7%2.9 $0.71 11/30/2022188,000 shares $117,970.00 -5.8%0.5%2.5 $0.63 11/15/2022199,600 shares $143,712.00 -19.4%0.5%2.5 $0.72 10/31/2022247,500 shares $180,675.00 +23.9%0.6%2.6 $0.73 10/15/2022199,700 shares $141,767.03 +3.2%0.5%1.9 $0.71 9/30/2022193,500 shares $160,605.00 -9.8%0.5%1.8 $0.83Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. 9/15/2022214,400 shares $218,688.00 -1.1%0.6%1.9 $1.02 8/31/2022216,700 shares $225,368.00 +22.9%0.6%1.8 $1.04 8/15/2022176,300 shares $205,883.14 -22.7%0.5%1.4 $1.17 7/31/2022228,100 shares $187,042.00 -14.2%0.6%1.7 $0.82 7/15/2022265,700 shares $215,217.00 -21.4%0.7%1.9 $0.81 6/30/2022338,000 shares $260,260.00 -11.8%0.9%2.2 $0.77 6/15/2022383,300 shares $295,141.00 -29.4%1.0%2.3 $0.77 5/31/2022542,900 shares $514,397.75 -5.0%1.4%2.2 $0.95 5/15/2022571,400 shares $511,345.86 -24.8%1.5%2 $0.89 4/30/2022759,800 shares $805,388.00 +4.7%2.0%2.4 $1.06 4/15/2022725,900 shares $863,821.00 -5.4%1.9%2.2 $1.19 3/31/2022767,700 shares $998,010.00 -7.3%N/A2.2 $1.30 3/15/2022828,000 shares $968,760.00 +33.2%2.1%2.1 $1.17 2/28/2022621,700 shares $808,210.00 -9.5%1.6%1.9 $1.30 2/15/2022687,200 shares $872,744.00 -10.2%1.8%2.1 $1.27 1/31/2022765,000 shares $1.06 million +3.5%2.0%2.2 $1.39 1/15/2022739,000 shares $1.16 million +47.4%N/A2.2 $1.57 12/31/2021501,300 shares $822,132.00 -16.8%1.3%1.6 $1.64 12/15/2021602,500 shares $1.10 million +20.9%1.6%2 $1.82 11/30/2021498,400 shares $991,816.00 +5.3%1.3%1.7 $1.99 11/15/2021473,500 shares $1.16 million -14.1%1.2%1.3 $2.45 10/29/2021551,100 shares $1.44 million -33.2%1.5%1.7 $2.61 10/15/2021825,300 shares $2.21 million +9.9%2.2%2.4 $2.68 9/30/2021751,300 shares $1.98 million +1.2%2.0%2.2 $2.64 9/15/2021742,200 shares $2.03 million +26.3%2.0%2.1 $2.74 8/31/2021587,600 shares $1.76 million -22.5%1.5%1.6 $3.00 8/13/2021758,600 shares $2.26 million +17.1%2.0%2.1 $2.98 7/30/2021647,900 shares $1.85 million -6.8%1.7%1.7 $2.86 7/15/2021694,900 shares $2.14 million -11.6%1.8%1.7 $3.08 6/30/2021786,200 shares $2.69 million -4.0%2.1%1.7 $3.42 6/15/2021818,800 shares $2.97 million -16.6%2.2%1.5 $3.63 5/28/2021981,400 shares $3.42 million -16.8%2.6%1.6 $3.48 5/14/20211,180,000 shares $3.89 million +30.0%3.1%1.3 $3.30 4/30/2021908,000 shares $4.11 million -11.0%2.4%0.8 $4.53 4/15/20211,020,000 shares $4.72 million +18.3%N/A0 $4.63 3/31/2021862,000 shares $4.01 million +0.9%2.3%0.5 $4.65 3/15/2021854,100 shares $4.77 million -38.6%2.6%0.4 $5.59 2/26/20211,390,000 shares $8.44 million +0.7%4.6%0.7 $6.07 2/12/20211,380,000 shares $13.72 million -16.9%4.6%0.7 $9.94 1/29/20211,660,000 shares $10.54 million +4.4%5.8%0.9 $6.35 1/15/20211,590,000 shares $9.46 million +62.2%5.3%1 $5.95 12/31/2020980,100 shares $4.80 million +68.6%3.6%0.7 $4.90 12/15/2020581,200 shares $2.30 million +56.3%2.1%0.5 $3.96 11/30/2020371,900 shares $1.10 million +17.8%1.4%0.3 $2.96 11/15/2020315,800 shares $802,132.00 +16.8%1.2%0.3 $2.54 10/30/2020270,400 shares $803,088.00 -27.9%1.2%0.3 $2.97 10/15/2020374,900 shares $1.42 million -47.0%1.6%0.4 $3.80 9/30/2020706,900 shares $2.80 million +1,022.1%3.8%0.9 $3.96 9/15/202063,000 shares $168,210.00 -37.5%0.3%0.1 $2.67 8/31/2020100,800 shares $208,656.00 +90.9%0.5%0.3 $2.07Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. 8/14/202052,800 shares $73,920.00 -2.4%0.3%0.3 $1.40 7/31/202054,100 shares $56,285.64 -5.6%0.3%0.4 $1.04 7/15/202057,300 shares $55,581.00 +62.3%0.3%0.5 $0.97 6/30/202035,300 shares $35,289.41 -18.9%0.2%0.4 $1.00 6/15/202043,500 shares $45,240.00 -24.5%0.2%0.6 $1.04 5/29/202057,600 shares $60,480.00 +11.0%0.3%1.6 $1.05 5/15/202051,900 shares $52,938.00 -29.7%0.3%2.6 $1.02 4/30/202073,800 shares $82,929.06 +64.7%0.4%3.4 $1.12 4/15/202044,800 shares $47,040.00 +11.4%N/A2.2 $1.05 3/31/202040,200 shares $42,210.00 -61.6%N/A2 $1.05 3/13/2020104,800 shares $115,280.00 +147.8%N/A3.2 $1.10 2/28/202042,300 shares $38,493.00 +94.9%N/A2 $0.91 2/14/202021,700 shares $21,917.00 -32.6%0.1%1.2 $1.01 1/31/202032,200 shares $45,080.00 +7.7%0.2%2.2 $1.40 1/15/202029,900 shares $42,458.00 -26.7%0.1%3 $1.42 12/31/201940,800 shares $69,360.00 +229.0%0.2%4.6 $1.70 EVGN Short Interest - Frequently Asked Questions What is Evogene's current short interest? Short interest is the volume of Evogene shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 62,400 shares of EVGN short. Learn More on Evogene's current short interest. What is a good short interest ratio for Evogene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVGN shares currently have a short interest ratio of 1.0. Learn More on Evogene's short interest ratio. Is Evogene's short interest increasing or decreasing? Evogene saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 62,400 shares, a decline of 36.2% from the previous total of 97,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evogene's short interest compare to its competitors? Here is how the short interest of companies compare to Evogene: ImmunoPrecise Antibodies Ltd. (0.93%), Bolt Biotherapeutics, Inc. (8.82%), Singular Genomics Systems, Inc. (0.98%), T2 Biosystems, Inc. (22.49%), JanOne Inc. (2.92%), Viracta Therapeutics, Inc. (2.42%), SeaStar Medical Holding Co. (2.98%), NeuroOne Medical Technologies Co. (1.11%), Spectral AI, Inc. (5.48%), Femasys Inc. (4.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Evogene stock? Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. EVGN shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evogene? A short squeeze for Evogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further. How often is Evogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ImmunoPrecise Antibodies Short Interest Data Bolt Biotherapeutics Short Interest Data Singular Genomics Systems Short Interest Data T2 Biosystems Short Interest Data JanOne Short Interest Data Viracta Therapeutics Short Interest Data SeaStar Medical Short Interest Data NeuroOne Medical Technologies Short Interest Data Spectral AI Short Interest Data Femasys Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVGN) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.